Acquisition History / Jagsonpal Pharmaceuticals / Aequitas Healthcare

Jagsonpal Pharmaceuticals Acquires Aequitas Healthcare

Announced June 29, 2026 — $2.3M

Jagsonpal PharmaceuticalsPharmaceuticals2026

What happened

Jagsonpal Pharmaceuticals acquired a 85% stake in Aequitas Healthcare, an Indian pharmaceuticals business, for Rs 20.08 crore. The transaction was recorded in PrivateCircle's June 2026 India acquisition roundup, which tracks deal disclosures by listed and unlisted Indian companies.

Acquirer
Jagsonpal Pharmaceuticals
Target
Aequitas Healthcare
Announced
June 29, 2026
Price
$2.3M
Industry
Pharmaceuticals
Buyer type
Strategic acquirer
Status
Announced, not yet closed

By the numbers

Jagsonpal Pharmaceuticals's acquisition history
1st of 1 tracked deals
Disclosed prices
1 of 1 Jagsonpal Pharmaceuticals deals
Jagsonpal Pharmaceuticals's average disclosed price
$2.3M
Jagsonpal Pharmaceuticals's largest disclosed deal
Aequitas Healthcare ($2.3M)
Tracked acquisitions in 2026
397 across all acquirers
Jagsonpal Pharmaceuticals in Pharmaceuticals
1 acquisition

Frequently Asked Questions About This Acquisition

When did Jagsonpal Pharmaceuticals acquire Aequitas Healthcare?

Jagsonpal Pharmaceuticals acquired Aequitas Healthcare on June 29, 2026. This was Jagsonpal Pharmaceuticals's 1st publicly tracked acquisition out of 1 we have on record.

How much did Jagsonpal Pharmaceuticals pay for Aequitas Healthcare?

Jagsonpal Pharmaceuticals paid $2.3M for Aequitas Healthcare.

What does Aequitas Healthcare do?

Jagsonpal Pharmaceuticals acquired a 85% stake in Aequitas Healthcare, an Indian pharmaceuticals business, for Rs 20.08 crore. The transaction was recorded in PrivateCircle's June 2026 India acquisition roundup, which tracks deal disclosures by listed and unlisted Indian companies.

What other Pharmaceuticals companies has Jagsonpal Pharmaceuticals acquired?

Aequitas Healthcare is Jagsonpal Pharmaceuticals's only publicly tracked acquisition in Pharmaceuticals so far.

Read the full article →

More Pharmaceuticals acquisitions